Published in J Immunol on October 01, 1997
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci U S A (2010) 2.36
The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol (2010) 2.23
Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses. J Immunol (2012) 1.13
The evolution of multiple isotypic IgM heavy chain genes in the shark. J Immunol (2008) 0.94
Natural antibody - Biochemistry and functions. Glob J Biochem (2011) 0.76
Phosphocholine-Specific Antibodies Improve T-Dependent Antibody Responses against OVA Encapsulated into Phosphatidylcholine-Containing Liposomes. Front Immunol (2016) 0.75
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (1995) 17.42
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science (1985) 12.75
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
Hepatitis C virus replication in mice with chimeric human livers. Nat Med (2001) 5.87
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A (1984) 4.90
Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 4.37
Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (1984) 4.35
Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci U S A (1977) 3.13
The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res (1980) 2.97
Tularaemia in Sheep. Can J Comp Med Vet Sci (1942) 2.81
The coding function of nucleotide sequences can be discerned by statistical analysis. J Theor Biol (1981) 2.61
Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci U S A (1982) 2.44
Deletions in immunoglobulin mu chains. EMBO J (1982) 2.35
Production of functional chimaeric mouse/human antibody. Nature (1985) 2.35
Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J Immunol (1984) 2.27
Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 2.16
The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J Immunol (1984) 2.14
Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells. Proc Natl Acad Sci U S A (1984) 2.12
Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci U S A (1983) 2.03
Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. Nucleic Acids Res (1985) 2.01
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature (1987) 1.93
Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proc Natl Acad Sci U S A (1986) 1.90
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J Virol (1990) 1.86
T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells. Science (1984) 1.82
Properties of recombination-deficient mutants of bacteriophage lambda. J Mol Biol (1970) 1.80
Structure and function of immunoglobulin domains. V. Binding, University of immunoglobulin G and fragments to placental membrane preparations. J Immunol (1976) 1.78
The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1. J Immunol (1976) 1.70
Homologous recombination can restore normal immunoglobulin production in a mutant hybridoma cell line. Proc Natl Acad Sci U S A (1988) 1.70
Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses. Science (1984) 1.69
Structure of simian immunodeficiency virus regulatory genes. Proc Natl Acad Sci U S A (1989) 1.65
Mutations affecting the structure and function of immunoglobulin M. Mol Cell Biol (1982) 1.58
Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry (1981) 1.58
Immunoglobulin production by lymphocyte hybridomas. Eur J Immunol (1978) 1.56
Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene. Mol Cell Biol (1984) 1.55
Relation of HTLV-4 to simian and human immunodeficiency-associated viruses. Nature (1987) 1.53
Gene replacement with one-sided homologous recombination. Mol Cell Biol (1992) 1.51
Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production. Nature (1983) 1.51
X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science (1998) 1.46
A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography. J Immunol (1974) 1.44
Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc Natl Acad Sci U S A (1981) 1.41
IgM--molecular requirements for its assembly and function. Immunol Today (1989) 1.38
Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc Natl Acad Sci U S A (1991) 1.23
Transcriptional modulation of human T-cell growth factor gene by phorbol ester and interleukin 1. Biochemistry (1984) 1.21
New att mutants of phage lambda. Virology (1976) 1.20
The identification of a previously unrecognized subcomponent of the first component of complement. J Immunol (1975) 1.18
The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase. J Immunol (1980) 1.18
Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc Natl Acad Sci U S A (1990) 1.17
Clq inhibition of the interaction of collagen with human platelets. J Immunol (1976) 1.16
On the linkage between RNA processing and RNA translatability. J Biol Chem (1994) 1.14
B and T cells are not required for the viable motheaten phenotype. J Exp Med (1996) 1.14
Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element. Hum Gene Ther (1995) 1.12
Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity. Mol Immunol (1996) 1.11
On the structure of polymeric IgM. Eur J Immunol (1988) 1.11
Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact. J Biol Chem (1987) 1.08
Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med (1988) 1.08
Complement fixing and macrophage opsonizing activities associated with beta2 microglobulin. Immunol Commun (1974) 1.08
Calcium binding properties of the C1 subcomponents C1q, C1r and C1s. FEBS Lett (1980) 1.07
Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain. EMBO J (1989) 1.07
Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgG1 for binding to the Fc receptor of human monocytes. J Immunol (1980) 1.07
Analysis of hybridoma mutants defective in synthesis of immunoglobulin M. Somat Cell Mol Genet (1986) 1.06
Folding pathways of immunoglobulin domains. The folding kinetics of the Cgamma3 domain of human IgG1. Biochemistry (1979) 1.06
The structure and function of immunoglobulin domains: studies with beta-2-microglobulin on the role of the intrachain disulfide bond. Proc Natl Acad Sci U S A (1975) 1.05
Structure and function of immunoglobulin domains. VII. Studies on the structural requirements of human immunoglobulin G for granulocyte binding. J Immunol (1978) 1.05
Structure and function of immunoglobulin domains. III. Isolation and characterization of a fragment corresponding to the Cgamma2 homology region of human immunoglobin G1. J Immunol (1976) 1.04
Variegated expression of the endogenous immunoglobulin heavy-chain gene in the absence of the intronic locus control region. Mol Cell Biol (1999) 1.03
Nucleotide sequences of immunoglobulin mu heavy chain deletion mutants. Nucleic Acids Res (1983) 1.03
Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18). J Biol Chem (1992) 1.03
Cellular and molecular restrictions of the lymphocyte fusion. Curr Top Microbiol Immunol (1978) 1.02
A hit-and-run system for introducing mutations into the Ig H chain locus of hybridoma cells by homologous recombination. J Immunol (1993) 1.02
Evidence for the domain hypothesis: location of the site of cytophilic activity toward guinea pig macrophages in the C H 3 homology region of human immunoglobulin G. J Immunol (1973) 1.02
The macromolecular structure of the first component of complement. J Immunol (1975) 1.01
Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J Biol Chem (1999) 1.01
The ultrastructure of C1t, a subcomponent of the first component of complement: an E.M. and ultracentrifuge study. J Immunol (1976) 1.01
Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). J Immunol (2000) 1.01
Homologous recombination between transferred and chromosomal immunoglobulin kappa genes. Mol Cell Biol (1988) 1.01
Immunoglobulin mu and gamma heavy chain classes are not determined by class-specific RNA-splicing enzymes. Nature (1978) 1.00
Erythropoietin sensitivity of rat bone marrow cells separated by velocity sedimentation. Cell Tissue Kinet (1970) 1.00
3'-orf and sor genes of human immunodeficiency virus: in vitro transcription-translation and immunoreactive domains. Proc Natl Acad Sci U S A (1987) 0.99
Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions. Mol Cell Biol (1997) 0.99
Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM. AIDS Res Hum Retroviruses (1987) 0.99
A plasma protein fractionation procedure for use in studies of protein metabolism. Biochem J (1974) 0.99
Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces. J Immunol (1986) 0.98
Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies. J Biol Chem (1983) 0.97
Inhibition of RNA directed DNA polymerase of murine leukemia virus by 2'-O-alkylated polyadenylic acids. Biochem Biophys Res Commun (1974) 0.97
Structural basis for the preferential association of autologous immunoglobulin subunits: role of the J region of the light chain. Mol Immunol (1984) 0.97
Model for wandering restriction enzymes. Nature (1974) 0.97
Infrequent translation of a nonsense codon is sufficient to decrease mRNA level. Mol Biol Cell (1999) 0.96
Transcriptional regulation of a tumor promoter and mitogen-inducible gene in human lymphocytes. Mol Cell Biol (1984) 0.96
The structure and function of the third component of human complement--I. The nature and extent of conformational changes accompanying C3 activation. Mol Immunol (1981) 0.96
Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain. Proc Natl Acad Sci U S A (1986) 0.95
Sequence complexity of polyadenylated RNA in human breast carcinoma cells. Int J Biochem (1982) 0.95
Conformational and functional changes in the fourth component of human complement produced by nucleophilic modification and by proteolysis with C1s-. Biochemistry (1982) 0.94
Fragmentation of immunoglobulin during storage. Can J Biochem (1966) 0.93
Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation. J Biol Chem (1992) 0.93
Correlation between the exposure of aromatic chromophores at the surface of the Fc domains of immunoglobulin G and their ability to bind complement. Biochemistry (1977) 0.93
Assembly of IgM. Role of disulfide bonding and noncovalent interactions. J Immunol (1995) 0.93